AffVille.i
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AffVille.i » - entrée « Marseille »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Marrakech < Marseille < Mayence  Facettes :

List of bibliographic references indexed by Marseille

Number of relevant bibliographic references: 67.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000004 (2021) Stéphane Honoré [France] ; Philippe Gautret [France]Reply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients.
000011 (2021) Matthieu Million [France] ; Audrey Giraud-Gatineau [France] ; Jean-Christophe Lagier [France] ; Philippe Parola [France] ; Philippe Gautret [France] ; Didier Raoult [France]Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin.
000087 (2021) Romain Lutaud [France] ; Dimiti Scronias [France] ; Jeremy Ward [France] ; Pierre Verger [France]The hydroxychloroquine debate: a therapeutic dilemma for general practitioners.
000135 (2021) Baptiste Maille [France] ; Marie Wilkin [France] ; Matthieu Million [France] ; Noémie Rességuier [France] ; Frédéric Franceschi [France] ; Linda Koutbi-Franceschi [France] ; Jérôme Hourdain [France] ; Elisa Martinez [France] ; Maxime Zabern [France] ; Christophe Gardella [France] ; Hervé Tissot-Dupont [France] ; Jagmeet P. Singh [États-Unis] ; Jean-Claude Deharo [France] ; Laurent Fiorina [France]Smartwatch Electrocardiogram and Artificial Intelligence for Assessing Cardiac-Rhythm Safety of Drug Therapy in the COVID-19 Pandemic. The QT-logs study.
000150 (2021) Philippe Gautret [France] ; Stéphane Honoré [France] ; Jean-Christophe Lagier [France] ; Didier Raoult [France]Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients.
000193 (2021) Philippe Gautret [France] ; Van Thuan Hoang [Viêt Nam] ; Hervé Chaudet [France] ; Jean-Christophe Lagier [France] ; Didier Raoult [France]Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.
000194 (2021) Philippe Gautret [France] ; Van Thuan Hoang [Viêt Nam] ; Stéphane Honoré [France] ; Yanis Roussel [France] ; Matthieu Million [France] ; Jean-Christophe Lagier [France] ; Didier Raoult [France]Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
000195 (2021) Philippe Gautret [France] ; Van Thuan Hoang [Viêt Nam] ; Jean-Christophe Lagier [France] ; Didier Raoult [France]Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.
000224 (2021) Matthieu Million [France] ; Yanis Roussel [France] ; Jean-Christophe Lagier [France] ; Didier Raoult [France]Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al.
000228 (2021) Didier Raoult [France]Rational for meta-analysis and randomized treatment: the COVID-19 example.
000347 (2021) Benjamin Coiffard [France] ; Philipp M. Lepper [Allemagne] ; Eloi Prud'Homme [France] ; Florence Daviet [France] ; Nadim Cassir [France] ; Heinrike Wilkens [Allemagne] ; Sami Hraiech [France] ; Frank Langer [Allemagne] ; Pascal A. Thomas [France] ; Martine Reynaud-Gaubert [France] ; Robert Bals [Allemagne] ; Hans-Joachim Sch Fers [Allemagne] ; Laurent Papazian [France] ; Frederik Seiler [Allemagne]Management of lung transplantation in the COVID-19 era-An international survey.
000355 (2021) Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France]Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19.
000369 (2021) Philippe Colson [France] ; Bernard La Scola [France] ; Jean-Christophe Lagier [France] ; Philippe Gautret [France] ; Didier Raoult [France]Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19.
000371 (2021) Serena Romani [France] ; Alexandre Gérard [France] ; Audrey Fresse [France] ; Delphine Viard [France] ; Élise Van-Obberghen [France] ; Joëlle Micallef [France] ; Fanny Rocher [France] ; Milou-Daniel Drici [France]Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID-19 Epidemic.
000448 (2021) Philippe Gautret [France] ; Jean-Christophe Lagier [France] ; Stéphane Honoré [France] ; Van Thuan Hoang [Viêt Nam] ; Philippe Colson [France] ; Didier Raoult [France]Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited.
000455 (2021) Matthieu Million [France] ; Herve Chaudet [France] ; Didier Raoult [France]Hydroxychloroquine Failure: The End Does Not Justify the Means.
000489 (2021) Jean Gaudart [France] ; Jordi Landier [France] ; Laetitia Huiart [Luxembourg (pays)] ; Eva Legendre [France] ; Laurent Lehot [France] ; Marc Karim Bendiane [France] ; Laurent Chiche [France] ; Aliette Petitjean [France] ; Emilie Mosnier [France] ; Fati Kirakoya-Samadoulougou [Belgique] ; Jacques Demongeot [France] ; Renaud Piarroux [France] ; Stanislas Rebaudet [France]Factors associated with the spatial heterogeneity of the first wave of COVID-19 in France: a nationwide geo-epidemiological study.
000540 (2021) Philippe Gautret [France] ; Van Thuan Hoang [Viêt Nam] ; Philippe Colson [France] ; Didier Raoult [France]Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann.
000541 (2021) Matthieu Million [France] ; Yanis Roussel [France] ; Philippe Gautret [France] ; Didier Raoult [France]Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
000542 (2021) Philippe Gautret [France] ; Van Thuan Hoang [Viêt Nam] ; Jean-Christophe Lagier [France] ; Didier Raoult [France]Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes.
000561 (2021) E. Chabrière [France]Does IHU-Méditerranée Infection influence Gilead Sciences' stock price?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AffVille.i -k "Marseille" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AffVille.i  \
                -Sk "Marseille" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AffVille.i
   |clé=    Marseille
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021